Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer
Authors
Keywords
Non-small cell lung cancer, MicroRNA-9, Clinicopathological features, Prognosis
Journal
Clinical & Translational Oncology
Volume 16, Issue 5, Pages 469-475
Publisher
Springer Nature
Online
2013-09-09
DOI
10.1007/s12094-013-1106-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-9, -31, and -182 Deregulation Promote Proliferation and Tumor Cell Survival in Colon Cancer
- (2015) Lina Cekaite et al. NEOPLASIA
- MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein
- (2013) Po-Lin Kuo et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
- (2013) Sajo Kaduthanam et al. LUNG CANCER
- microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1
- (2013) Liduan Zheng et al. PLoS One
- miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation
- (2012) J. Cai et al. CANCER RESEARCH
- Genetic and epigenetic factors in regulation of microRNA in colorectal cancers
- (2012) Serena Vinci et al. METHODS
- MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status
- (2012) Xin Zhou et al. PLoS One
- A Facile and Specific Assay for Quantifying MicroRNA by an Optimized RT-qPCR Approach
- (2012) Qian Mei et al. PLoS One
- Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer
- (2011) Urmo Võsa et al. GENES CHROMOSOMES & CANCER
- Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer
- (2011) Kengo Shigehara et al. PLoS One
- MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer Progression
- (2010) Xueqin Chen et al. CANCER RESEARCH
- A MicroRNA Expression Signature for Cervical Cancer Prognosis
- (2010) X. Hu et al. CANCER RESEARCH
- Prognostic significance of differentially expressed miRNAs in esophageal cancer
- (2010) Yuxin Hu et al. INTERNATIONAL JOURNAL OF CANCER
- Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
- (2010) M A T Hildebrandt et al. ONCOGENE
- MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1
- (2009) Li-Min Guo et al. FEBS Journal
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MiR-92b and miR-9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors
- (2008) Dvora Nass et al. BRAIN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now